Pharmacology Flashcards
PPIs - Mechanism
Covalently bind to and irreversibly inactivate H/K/ATPase
Results in a 80-95% reduction in daily acid production; may take 2-5 days to reach steady state inhibition
PPIs - Pharmacokinetics
Systemic absorption is improved by administration as enteric-coated capsules or with sodium bicarbonate
Administered on empty stomach 1 hour before meals so that peak plasma concentration occurs with maximal proton pump secretion
Metabolized by CYP450 in the liver; dosage reduction necessary in liver disease
PPIs - Clinical Uses
GERD - First line therapy
Peptic Ulcer Disease - H.pylori and NSAID-induced; for symptomatic relief and ulcer healing
Prevention of stress gastritis
Zollinger-Ellison syndrome
PPIs - Adverse Effects
Headache, abdominal pain, nausea, constipation/diarrhea
Hypergastrinemia resulting from chronic PPI use may cause rebound gastric acidity upon discontinuation
Omeprazole - DDIs
Inhibits conversion of Clopidogrel to active form leading to a hypercoagulable state
H2 receptor antagonists - Agents
Ranitidine
Cimetidine
Famotidine
Nizatidine
H2 receptor antagaonists - Mechanism
Reversible, competitive block at parietal H2 receptors on the basolateral membrane; normally, histamine binding to H2 receptors activates Gs, increasing intracellular cAMP and leading to phosphorylation of the H/K/ATPase, which activates it
H2 receptor antagonists vs. PPIs
Somewhat less effective than PPIs but still suppress 24 hour acid secretion by 70%
Better at blocking nocturnal acid secretion (90%) than meal-stimulated acid secretion (60-80%)
H2 receptor antagonists - Pharmacokinetics
Rapidly absorbed from GI tract; some enhancement with food, decreased with antacids
No dosage adjustment necessary for liver disease; dosage reduction IS required in renal dysfunction, especially in the elderly
H2 antagonists - Clinical Uses
GERD - OTC treatment for infrequent heartburn; PPIs preferred in severe disease
PUD - Useful for suppressing nocturnal acid secretion; PPIs preferred for more severe disease
H2 antagonists - Adverse Effects
Dizziness, diarrhea, constipation, headache
Rarely CNS dysfunction / mental status changes more commonly seen with Cimetidine in the elderly
Gynecomastia, galactorrhea, decreased sperm count - with high doses of Cimetidine
Sucralfate - Mechanism
Disaccharide aluminum salt; selectively binds to necrotic ulcer tissue to form a protective barrier which prevents pepsin from hydrolyzing mucosal proteins causing further erosion/ulceration
Sucralfate - Pharmacokinetics
Activated by pH < 4 - efficacy decreased by administration with antacids; best on empty stomach 1 hour before meals
No systemic absorption; administered 2-4x/day
Misoprostol - Mechanism
Prostaglandin (PGE1) analog - inhibits cAMP formation in gastric parietal cells, decreasing H+ secretion and stimulating bicarbonate and mucous secretion
Administered orally 3-4x/day
Misoprostol - Uses and Adverse Effects
Alleviation of NSAID-induced GI ulceration
Side effects: Diarrhea, uterine cramping (contraindicated during pregnancy)
Ca2+ Antacids - Adverse Effects
Constipation
With long-term use: hypercalcemia, renal calculi, rebound acid secretion